Matthew P. Patricelli, Ph.D.
Affiliations: | 2001 | Scripps Research Institute, La Jolla, La Jolla, CA, United States |
Area:
Medicinal ChemistryGoogle:
"Matthew Patricelli"Mean distance: 18.87 | S | N | B | C | P |
Parents
Sign in to add mentor| Benjamin F. Cravatt | grad student | 2001 | Scripps Institute | |
| (Biochemical and physiological investigations of fatty acid amide hydrolase.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kavanagh ME, Horning BD, Khattri R, et al. (2022) Author Correction: Selective inhibitors of JAK1 targeting an isoform-restricted allosteric cysteine. Nature Chemical Biology |
| Kavanagh ME, Horning BD, Khattri R, et al. (2022) Selective inhibitors of JAK1 targeting an isoform-restricted allosteric cysteine. Nature Chemical Biology |
| Baltgalvis K, Kikuchi S, Symons K, et al. (2020) Abstract 6411: Discovery of covalent ligands to novel E3 ligases enables bispecific degraders with highly differentiated protein degradation across a broad range of targets Cancer Research. 80: 6411-6411 |
| Janes MR, Zhang J, Li LS, et al. (2018) Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor. Cell. 172: 578-589.e17 |
| Okerberg ES, Hainley A, Brown H, et al. (2017) Correction: Identification of a Tumor Specific, Active-Site Mutation in Casein Kinase 1α by Chemical Proteomics. Plos One. 12: e0172649 |
| Matthews JM, Bhatt S, Patricelli MP, et al. (2016) Pathophysiological significance and therapeutic targeting of germinal center kinase in diffuse large B-cell lymphoma. Blood |
| Okerberg ES, Hainley A, Brown H, et al. (2016) Identification of a Tumor Specific, Active-Site Mutation in Casein Kinase 1α by Chemical Proteomics. Plos One. 11: e0152934 |
| Patricelli MP, Janes MR, Li LS, et al. (2016) Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State. Cancer Discovery |
| Kessler L, Chen J, Guo X, et al. (2016) KO-947, a potent and selective ERK inhibitor with slow dissociation kinetics European Journal of Cancer. 69: S126 |
| Kessler L, Wu T, Grembecka J, et al. (2016) Discovery of novel menin-MLL small molecule inhibitors that display high potency and selectivity in vitro and in vivo European Journal of Cancer. 69 |